Abeona Therapeutics Inc. (ABEO) Earnings Calendar & Upcoming Events

Abeona Therapeutics Inc. (ABEO) — Price $5.37 HealthcareBiotechnology — NASDAQ

Latest reported results:

Corporate calendar for Abeona Therapeutics Inc. (ABEO): upcoming earnings dates, dividend ex-dates and payment dates, stock splits, shareholder meetings and conference calls. Plan your positions around the key catalysts.

Abeona Therapeutics Inc. is a biopharmaceutical company in the clinical development stage, focused on creating innovative gene and cell therapies to address severe and uncommon genetic diseases. Its leading program, EB-101, an autologous gene-corrected cell therapy, is presently in a Phase III clinical trial for treating recessive dystrophic epidermolysis bullosa.

Dividend History

DateAmountYield
2000-03-31$0.593044.17%

Price

Price$5.37
Market Cap$306M
ExchangeNASDAQ
CountryUS

Related companies: ARCT · ASMB · ELDN · FHTX · HUMA · PBYI · SGMT

Explore sector: Healthcare · Biotechnology

More sections of ABEO: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · News

Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks